Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 4797856, 12 pages
https://doi.org/10.1155/2017/4797856
Research Article

Difference in Antibody Responses to Mycobacterium tuberculosis Antigens in Japanese Tuberculosis Patients Infected with the Beijing/Non-Beijing Genotype

1Division of Emerging Infectious Diseases, Department of Internal Medicine, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan
2Laboratory of Disaster-Related Infectious Disease, International Research Institute of Disaster Science, Tohoku University, Sendai, Miyagi 980-8574, Japan
3Fukujuji Hospital, Japan Anti-Tuberculosis Association, 3-1-2 4 Matsuyama, Kiyose, Tokyo 204-8533, Japan
4Microbiological Research Institute, Otsuka Pharmaceutical Co., Ltd., Kawauchi-cho, Tokushima 771-0192, Japan
5Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido 001-0020, Japan
6Division of Bacteriology, Department of Microbiology and Immunology, Faculty of Medicine, Tottori University, Yonago, Tottori 683-8503, Japan
7Graduate School of Health Science Studies, Kibi International University, 8 Igamachi, Takahashi 716-8508, Japan

Correspondence should be addressed to Toshio Hattori; pj.ca.iuik@tirottah

Received 18 October 2016; Accepted 8 December 2016; Published 15 January 2017

Academic Editor: Andréia M. Cardoso

Copyright © 2017 Jingge Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Global Tuberculosis Report 2014, World Health Organization, Geneva, Switzerland, 2014.
  2. P. J. Bifani, B. Mathema, N. E. Kurepina, and B. N. Kreiswirth, “Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains,” Trends in Microbiology, vol. 10, no. 1, pp. 45–52, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Parwati, R. van Crevel, and D. van Soolingen, “Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains,” The Lancet Infectious Diseases, vol. 10, no. 2, pp. 103–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. N. T. L. Hang, S. Maeda, N. Keicho, P. H. Thuong, and H. Endo, “Sublineages of Mycobacterium tuberculosis Beijing genotype strains and unfavorable outcomes of anti-tuberculosis treatment,” Tuberculosis, vol. 95, no. 3, pp. 336–342, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Wang, Y. Liu, C.-L. Zhang et al., “Genotypes and characteristics of clustering and drug susceptibility of mycobacterium tuberculosis isolates collected in heilongjiang province, China,” Journal of Clinical Microbiology, vol. 49, no. 4, pp. 1354–1362, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Bauer, Å. B. Andersen, K. Kremer, and H. Miörner, “Usefulness of spoligotyping to discriminate IS6110 low-copy-number Mycobacterium tuberculosis complex strains cultured in Denmark,” Journal of Clinical Microbiology, vol. 37, no. 8, pp. 2602–2606, 1999. View at Google Scholar · View at Scopus
  7. B. Shiratori, S. Leano, C. Nakajima et al., “Elevated OPN, IP-10, and neutrophilia in loop-mediated isothermal amplification confirmed tuberculosis patients,” Mediators of Inflammation, vol. 2014, Article ID 513263, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. P. I. Cafrune, L. G. Possuelo, A. W. Ribeiro et al., “Prospective study applying spoligotyping directly to DNA from sputum samples of patients suspected of having tuberculosis,” Canadian Journal of Microbiology, vol. 55, no. 7, pp. 895–900, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Suresh, J. Arora, H. Pant, T. Rana, and U. B. Singh, “Spoligotyping of Mycobacterium tuberculosis DNA from Archival Ziehl-Neelsen-stained sputum smears,” Journal of Microbiological Methods, vol. 68, no. 2, pp. 291–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D. P. Cifuentes, M. Ocampo, H. Curtidor et al., “Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen,” BMC Microbiology, vol. 10, article 109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Matsuba, Y. Suzuki, and Y. Tanaka, “Association of the Rv0679c protein with lipids and carbohydrates in Mycobacterium tuberculosis/Mycobacterium bovis BCG,” Archives of Microbiology, vol. 187, no. 4, pp. 297–311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Nakajima, A. Tamaru, Z. Rahim et al., “Simple multiplex PCR assay for identification of Beijing family Mycobacterium tuberculosis isolates with a lineage-specific mutation in Rv0679c,” Journal of Clinical Microbiology, vol. 51, no. 7, pp. 2025–2032, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Y. Armitige, C. Jagannath, A. R. Wanger, and S. J. Norris, “Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages,” Infection and Immunity, vol. 68, no. 2, pp. 767–778, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. H. G. Wiker and M. Harboe, “The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis,” Microbiological Reviews, vol. 56, no. 4, pp. 648–661, 1992. View at Google Scholar · View at Scopus
  15. A. Geluk, K. E. Van Meijgaarden, K. L. M. C. Franken et al., “Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans,” Journal of Immunology, vol. 165, no. 11, pp. 6463–6471, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Li, H. Li, W.-Z. Zuo et al., “The viability and protein expression of Beijing/W Lineage mycobacterium tuberculosis circulating in Xinjiang, China,” Current Microbiology, vol. 70, no. 5, pp. 735–744, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Pheiffer, J. C. Betts, H. R. Flynn, P. T. Lukey, and P. van Helden, “Protein expression by a Beijing strain differs from that of another clinical isolate and Mycobacterium tuberculosis H37Rv,” Microbiology, vol. 151, no. 4, pp. 1139–1150, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Yuan, D. D. Crane, R. M. Simpson et al., “The 16-kDa α-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9578–9583, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Purkayastha, L. A. McCue, and K. A. McDonough, “Identification of a Mycobacterium tuberculosis putative classical nitroreductase gene whose expression is coregulated with that of the acr gene within macrophages, in standing versus shaking cultures, and under low oxygen conditions,” Infection and Immunity, vol. 70, no. 3, pp. 1518–1529, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Yuan, D. D. Crane, and C. E. Barry III, “Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial α-crystallin homolog,” Journal of Bacteriology, vol. 178, no. 15, pp. 4484–4492, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Pethe, S. Alonso, F. Biet et al., “The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination,” Nature, vol. 412, no. 6843, pp. 190–194, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Kong, M. D. Cave, L. Zhang et al., “Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates,” Journal of Clinical Microbiology, vol. 45, no. 2, pp. 409–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Matsumoto, M. Furugen, H. Yukitake, and T. Yamada, “The gene encoding mycobacterial DNA-binding protein I (MDPI) transformed rapidly growing bacteria to slowly growing bacteria,” FEMS Microbiology Letters, vol. 182, no. 2, pp. 297–301, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Fujita, T. Naka, M. R. McNeil, and I. Yano, “Intact molecular characterization of cord factor (trehalose 6,6′-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry,” Microbiology, vol. 151, no. 10, pp. 3403–3416, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Zhao, Z. Zhu, X. Zhang et al., “Evaluation of anti-TBGL antibody in the diagnosis of tuberculosis patients in China,” Journal of Immunology Research, vol. 2015, Article ID 834749, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Senoputra, B. Shiratori, F. M. Hasibuan et al., “Diagnostic value of antibody responses to multiple antigens from Mycobacterium tuberculosis in active and latent tuberculosis,” Diagnostic Microbiology and Infectious Disease, vol. 83, no. 3, pp. 278–285, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Azzurri, G. V. Kanaujia, O. Y. Sow et al., “Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea,” International Journal of Immunopathology and Pharmacology, vol. 19, no. 1, pp. 199–208, 2006. View at Google Scholar · View at Scopus
  28. WHO, Drug Susceptibility Testing, World Health Organization, Geneva, Switzerland, 2012.
  29. J. Kamerbeek, L. Schouls, A. Kolk et al., “Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology,” Journal of Clinical Microbiology, vol. 35, no. 4, pp. 907–914, 1997. View at Google Scholar · View at Scopus
  30. K. Brudey, J. R. Driscoll, L. Rigouts et al., “Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology,” BMC Microbiology, vol. 6, article no. 23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Hamasur, G. Källenius, and S. B. Svenson, “A new rapid and simple method for large-scale purification of mycobacterial lipoarabinomannan,” FEMS Immunology and Medical Microbiology, vol. 24, no. 1, pp. 11–17, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Mizusawa, M. Kawamura, M. Takamori et al., “Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis,” Clinical and Vaccine Immunology, vol. 15, no. 3, pp. 544–548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Matsuba, U. R. Siddiqi, T. Hattori et al., “Antigenic characterization of dimorphic surface protein in Mycobacterium tuberculosis,” FEMS Microbiology Letters, vol. 363, no. 10, 2016. View at Publisher · View at Google Scholar
  34. C. C. Perley, M. Frahm, E. M. Click et al., “The human antibody response to the surface of Mycobacterium tuberculosis,” PLoS ONE, vol. 9, no. 6, Article ID e98938, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Y.-G. Hur, A. Kim, Y. A. Kang et al., “Evaluation of antigen-specific immunoglobulin g responses in pulmonary tuberculosis patients and contacts,” Journal of Clinical Microbiology, vol. 53, no. 3, pp. 904–909, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Abebe and G. Bjune, “The protective role of antibody responses during Mycobacterium tuberculosis infection,” Clinical and Experimental Immunology, vol. 157, no. 2, pp. 235–243, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Osada-Oka, Y. Tateishi, Y. Hirayama et al., “Antigen 85A and mycobacterial DNA-binding protein 1 are targets of immunoglobulin G in individuals with past tuberculosis,” Microbiology and Immunology, vol. 57, no. 1, pp. 30–37, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A.-R. Shin, K.-S. Lee, J.-S. Lee et al., “Mycobacterium tuberculosis HBHA protein reacts strongly with the serum immunoglobulin M of tuberculosis patients,” Clinical and Vaccine Immunology, vol. 13, no. 8, pp. 869–875, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Gomes, S. A. Vinhas, B. Reis-Santos et al., “Extrapulmonary tuberculosis: Mycobacterium tuberculosis strains and host risk factors in a large urban setting in Brazil,” PLoS ONE, vol. 8, no. 10, Article ID e74517, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. T. A. Tessema, G. Bjune, B. Hamasur, S. Svenson, H. Syre, and B. Bjorvatn, “Circulating antibodies to lipoarabinomannan in relation to sputum microscopy, clinical features and urinary anti-lipoarabinomannan detection in pulmonary tuberculosis,” Scandinavian Journal of Infectious Diseases, vol. 34, no. 2, pp. 97–103, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Yu, R. Prados-Rosales, E. R. Jenny-Avital, K. Sosa, A. Casadevall, and J. M. Achkar, “Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status,” Clinical and Vaccine Immunology, vol. 19, no. 2, pp. 198–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Parwati, B. Alisjahbana, L. Apriani et al., “Mycobacterium tuberculosis beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia,” Journal of Infectious Diseases, vol. 201, no. 4, pp. 553–557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. U. R. Siddiqi, P. S. A. Leano, H. Chagan-Yasutan et al., “Frequent detection of anti-tubercular-glycolipid-IgG and -IgA antibodies in healthcare workers with latent tuberculosis infection in the Philippines,” Clinical and Developmental Immunology, vol. 2012, Article ID 610707, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Schierloh, L. Klepp, C. Vazquez et al., “Differential expression of immunogenic proteins on virulent Mycobacterium tuberculosis clinical isolates,” BioMed Research International, vol. 2014, Article ID 741309, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus